BioNTech co-founder 'confident' vaccine works against Indian variant

Agence France-Presse 2021-04-28

Views 1

BioNTech co-founder Ugur Sahin voices confidence that the vaccine his company jointly developed with Pfizer works against the Indian variant of the coronavirus. of Uğur Şahin
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA, tiniyak na mabisa ang COVID-19 vaccines vs. bagong variants; efficacy ng ilan pang COVID-19 vaccines vs. Delta variant, patuloy na pinag-aaralan
play
02:42

FDA, tiniyak na mabisa ang COVID-19 vaccines vs. bagong variants; efficacy ng ilan pang COVID-19 vaccines vs. Delta variant, patuloy na pinag-aaralan
Philippe Doucet : «L'écart entre les vaccinés et les non-vaccinés concernant le variant Delta est de 1 à 12»
play
00:34

Philippe Doucet : «L'écart entre les vaccinés et les non-vaccinés concernant le variant Delta est de 1 à 12»
Express Balita: PHL, inihalal bilang chairperson ng gov't group ng int'l labor organization; Importansya ng info drive hinggil sa COVID-19 vaccines, binigyang-diin; Theta variant, 'di na maituturing na ‘variant of interest’ dahil sa pagbaba ng bilang ng n
play
02:27

Express Balita: PHL, inihalal bilang chairperson ng gov't group ng int'l labor organization; Importansya ng info drive hinggil sa COVID-19 vaccines, binigyang-diin; Theta variant, 'di na maituturing na ‘variant of interest’ dahil sa pagbaba ng bilang ng n
Double mutant Covid variant: Will existing vaccines work on new variants?
play
35:38

Double mutant Covid variant: Will existing vaccines work on new variants?
Pagbahing at runny nose o sipon, posibleng sintomas ng COVID-19 Delta variant base sa ilang pag-aaral; Kumpletong doses ng COVID-19 vaccines, nananatiling epektibo vs. COVID-19 variants
play
02:29

Pagbahing at runny nose o sipon, posibleng sintomas ng COVID-19 Delta variant base sa ilang pag-aaral; Kumpletong doses ng COVID-19 vaccines, nananatiling epektibo vs. COVID-19 variants
OCTA Research Group, iginiit na mahalagang higpitan ang border control vs. COVID-19 variants; bibilhing 40-M doses ng Pfizer vaccines, makatutulong para mapabilis ang vaccine rollout
play
01:49

OCTA Research Group, iginiit na mahalagang higpitan ang border control vs. COVID-19 variants; bibilhing 40-M doses ng Pfizer vaccines, makatutulong para mapabilis ang vaccine rollout
ICMR On Vaccine-Escaping Omicron Variant Cases: Vaccines Are Disease Modifying Not Preventive
play
04:44

ICMR On Vaccine-Escaping Omicron Variant Cases: Vaccines Are Disease Modifying Not Preventive
Vaccine manufactures indicate existing vaccines may be ineffective against Omicron variant
play
05:29

Vaccine manufactures indicate existing vaccines may be ineffective against Omicron variant
Public health England: COVID-19 vaccines ng Pfizer at AstraZeneca, epektibo vs. Indian variant; Israel, tatapusin na ang pagpapatupad ng COVID-19 restrictions matapos ideklara na matagumpay ang vaccine rollout; British Prime Minister Boris Johnson, inan
play
02:11

Public health England: COVID-19 vaccines ng Pfizer at AstraZeneca, epektibo vs. Indian variant; Israel, tatapusin na ang pagpapatupad ng COVID-19 restrictions matapos ideklara na matagumpay ang vaccine rollout; British Prime Minister Boris Johnson, inan
EUA ng Pfizer, kailangan munang amyendahan bago magamit sa edad 12-15 sa Pilipinas; Vaccine Expert Panel, pinag-aaralan kung epektibo ang first generation vaccines vs. B.1.617 COVID-19 variant
play
03:07

EUA ng Pfizer, kailangan munang amyendahan bago magamit sa edad 12-15 sa Pilipinas; Vaccine Expert Panel, pinag-aaralan kung epektibo ang first generation vaccines vs. B.1.617 COVID-19 variant
562,770 doses ng Pfizer-BioNTech COVID-19 vaccines, dumating na sa bansa kagabi | UB
play
04:13

562,770 doses ng Pfizer-BioNTech COVID-19 vaccines, dumating na sa bansa kagabi | UB
FEMME ACTUELLE -
play
01:04

FEMME ACTUELLE - "Même les triples vaccinés sont susceptibles de transmettre la maladie" : l'alerte du PDG BioNTech